Company Analysis

Embecta Corp. (EMBC)

Nasdaq: EMBC · Surgical & Medical Instruments & Apparatus · Wilmington, DE · filing with the SEC since 2021
Grade5.0
◀ Past 5.2● Present 6.2▶ Future 3.2
1 est.

Who runs Embecta Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Kurdikar Devdatt
President and CEO. First filing Feb 2022, latest Aug 13, 2026, 2 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
19 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Kurdikar DevdattPresident and CEOFeb 2022Aug 13, 2026none
Elguicze JacobSVP and CFOFeb 2022Aug 13, 2026none
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLOApr 2022Aug 13, 2026none
Casner JeanChief Human Resources OfficerJul 2023Aug 11, 2026none
Roth Anthony M.VP, Chief Accounting OfficerDec 2024Jun 2, 2026none
Curtis ShaunSVP, Global Manuf./Sup. ChainApr 2022Dec 1, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Morris Milton MayodirectorApr 2022Sep 8, 20261 · $0.00
Hombach Robert J.directorMar 2022Aug 13, 2026none
Anderson Carrie LdirectorApr 2022Feb 13, 2026none
Pomeroy ClairedirectorApr 2022Feb 13, 2026none
Prange KarendirectorApr 2022Feb 13, 2026none
Reidy Christopher RdirectorApr 2022Feb 13, 2026none
Earlier names on the record8, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton EMBC · research, not advice